After Martin Shkreli raised the price of Daraprim, which costs one dollar to produce, from $13.50 per pill to $750 per pill, the public and media roundly panned the Turing Pharmaceuticals CEO for gouging patients in need of life-saving medicine.
While Shkreli’s move may have been extremely ostentatious, and drawn the public’s attention, the issue of overpriced drugs in America is one that is not confined to Shkreli and Turing Pharmaceuticals.
Drug prices in the U.S. have been skyrocketing for years. The latest data indicates that drug prices in the United States are often up to 10 times more expensive than in almost all other developed countries.
While some contend that this is a problem with the market itself, they are incorrect. It’s the government, not the market that is to blame for this situation.
The main reason why this situation exists is because of patents and intellectual property rights, a government granted monopoly privilege that has allowed these companies to claim a monopoly over a recipe for a particular medication.
In a truly free market someone like him may be able to develop a product and gouge the price, but his competitors […]
Pharma rips us off even if their products are cheap. Their products are often only marginally effective and the side effects are sometimes more catastrophic than the problem they are treating. Statins are a good example of this.